Value through Innovation27 July 2016

Clinical Study Results

  • Irampanel - Healthy
    Clinical Study Number 600.1
    Study Indication Healthy
    Product Irampanel
    Generic Name Irampanel
    Lab Code
    Clinical Phase I
    Study Title

    A single-blind, placebo-controlled single increasing dose tolerance study in healthy male volunteers after intravenous administration of BIIR 561 CL (dosage: 1 mg/h- 175 mg/h), infusion time 1 hour.

    Study Document Trial synopsis 600.1 english
  • Irampanel - Healthy
    Clinical Study Number 600.2
    Study Indication Healthy
    Product Irampanel
    Generic Name Irampanel
    Lab Code
    Clinical Phase I
    Study Title

    A single blind, placebo-controlled single increasing dose tolerance study in healthy male volunteers after intravenous administration of BIIR 561 CL as loading dose (dosage: 37.5 mg/h- 150 mg/h, infusion time 1 hour) followed by maintenance dose (dosage: 20 mg/h-40 to125 mg/h, infusion time 5 hours)

    Study Document Trial synopsis 600.2_CO english
  • Irampanel - Healthy
    Clinical Study Number 600.6
    Study Indication Healthy
    Product Irampanel
    Generic Name Irampanel
    Lab Code
    Clinical Phase I
    Study Title

    A single-blind, placebo-controlled single dose tolerance study in healthy elderly male and female volunteers after intravenous administration of BIIR 561 CL as loading dose (dosage: 75 mg/h, infusion time 1 hour) followed by maintenance dose (dosage: 40 mg/h and 75 mg/h,infusion time 5 hours)

    Study Document Trial synopsis 600.6_CO english

Clinical Trial Registry and structured study results. Find here protocol information for all clinical study types.

European Trial Register of EU studies.